Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients. [electronic resource]
Producer: 20120227Description: 407-9 p. digitalISSN:- 1365-2141
- Aged
- Antibodies, Bacterial -- biosynthesis
- Antibodies, Monoclonal, Murine-Derived -- pharmacology
- Antibody Formation -- drug effects
- Antineoplastic Agents -- pharmacology
- Bacterial Capsules -- immunology
- Combined Modality Therapy
- Female
- Haemophilus Vaccines -- immunology
- Haemophilus influenzae -- immunology
- Humans
- Lymphoma, B-Cell -- drug therapy
- Male
- Middle Aged
- Pneumococcal Vaccines -- immunology
- Polysaccharides, Bacterial
- Rituximab
- Streptococcus pneumoniae -- immunology
- Time Factors
- Vaccination
- Vaccines, Conjugate -- immunology
No physical items for this record
Publication Type: Comparative Study; Letter; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.